NCT06520267View on ClinicalTrials.gov

Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia

CompletedOBSERVATIONAL

Enrollment

131

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

June 12, 2021

Study Completion Date

August 15, 2021

Conditions

Bacteriuria in Symptomatic Benign Prostate HyperplasiaAntibiotic Susceptibility in Symptomatic Benign Prostate HyperplasiaTreatment Response to Antibiotics in Symptomatic Benign Prostate Hyperplasia

Interventions

DRUG

Antibiotic therapy

Urine culture and antibiotic sensitivity tests were conducted to assess the bacteriological profile. The patients were then prescribed antibiotics based on susceptibility testing for a duration of 1 week.

Trial Locations (1)

56700

BP Koirala Institute of Health Sciences, Dharān

All Listed Sponsors

lead

Tribhuvan University Teaching Hospital, Institute Of Medicine.

OTHER

NCT06520267 - Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter